Twin Peaks Wealth Advisors’s Soleno Therapeutics SLNO Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$33	–	1875
2026 Q1	$33	Buy	+1	New	+$39	﹤0.01%	2327
2025 Q3	–	Sell	-8	Closed	-$667	–	1794
2025 Q2	$667	Buy	+8	New	+$599	﹤0.01%	1855

Twin Peaks Wealth Advisors's SLNO Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 1 share — an estimated $33 sold.

Twin Peaks Wealth Advisors first reported a position in SLNO in Q2 2025 and held it in 2 quarters. The position peaked at $667 in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Twin Peaks Wealth Advisors reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Twin Peaks Wealth Advisors sold 1 Soleno Therapeutics share in Q2 2026, an estimated $33.
Twin Peaks Wealth Advisors first reported a position in Soleno Therapeutics in Q2 2025 and held it in 2 quarters.
Twin Peaks Wealth Advisors's Soleno Therapeutics position peaked at $667 in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.